A detailed history of Nisa Investment Advisors, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 1,070 shares of SRPT stock, worth $128,667. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,070
Previous 915 16.94%
Holding current value
$128,667
Previous $144,000 7.64%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$124.33 - $156.75 $19,271 - $24,296
155 Added 16.94%
1,070 $133,000
Q2 2024

Jul 19, 2024

SELL
$113.33 - $163.85 $3,399 - $4,915
-30 Reduced 3.17%
915 $144,000
Q1 2024

May 01, 2024

BUY
$93.7 - $141.53 $56,220 - $84,918
600 Added 173.91%
945 $122,000
Q3 2023

Nov 02, 2023

SELL
$102.5 - $123.59 $830,557 - $1 Million
-8,103 Reduced 95.92%
345 $41,000
Q2 2023

Aug 11, 2023

SELL
$106.4 - $157.19 $175,240 - $258,891
-1,647 Reduced 16.32%
8,448 $967,000
Q1 2023

May 02, 2023

BUY
$117.53 - $155.99 $1.14 Million - $1.51 Million
9,710 Added 2522.08%
10,095 $1.39 Million
Q3 2022

Nov 07, 2022

SELL
$75.71 - $119.24 $11,735 - $18,482
-155 Reduced 28.7%
385 $43,000
Q2 2022

Aug 03, 2022

SELL
$62.69 - $88.44 $21,941 - $30,954
-350 Reduced 39.33%
540 $40,000
Q1 2022

Apr 29, 2022

SELL
$63.15 - $90.42 $84,684 - $121,253
-1,341 Reduced 60.11%
890 $70,000
Q4 2021

Feb 03, 2022

SELL
$77.28 - $99.42 $65,688 - $84,507
-850 Reduced 27.59%
2,231 $160,000
Q3 2021

Oct 18, 2021

SELL
$65.97 - $92.48 $63,727 - $89,335
-966 Reduced 23.87%
3,081 $285,000
Q2 2021

Aug 06, 2021

SELL
$69.38 - $86.75 $97,132 - $121,450
-1,400 Reduced 25.7%
4,047 $315,000
Q1 2021

Apr 26, 2021

SELL
$72.25 - $168.95 $59,606 - $139,383
-825 Reduced 13.15%
5,447 $406,000
Q4 2020

Jan 25, 2021

BUY
$125.56 - $178.74 $189,721 - $270,076
1,511 Added 31.74%
6,272 $1.07 Million
Q3 2020

Oct 20, 2020

SELL
$127.12 - $172.34 $283,096 - $383,801
-2,227 Reduced 31.87%
4,761 $669,000
Q2 2020

Jul 27, 2020

BUY
$93.0 - $171.7 $252,774 - $466,680
2,718 Added 63.65%
6,988 $1.12 Million
Q1 2020

Apr 17, 2020

BUY
$82.38 - $131.64 $251,259 - $401,501
3,050 Added 250.0%
4,270 $418,000
Q4 2019

Jan 17, 2020

SELL
$76.53 - $135.58 $109,055 - $193,201
-1,425 Reduced 53.88%
1,220 $157,000
Q3 2019

Oct 17, 2019

BUY
$72.81 - $156.91 $96,109 - $207,121
1,320 Added 99.62%
2,645 $199,000
Q2 2019

Jul 12, 2019

BUY
$112.21 - $151.95 $14,026 - $18,993
125 Added 10.42%
1,325 $201,000
Q1 2019

Apr 17, 2019

SELL
$106.67 - $151.68 $204,379 - $290,618
-1,916 Reduced 61.49%
1,200 $143,000
Q4 2018

Jan 17, 2019

BUY
$97.32 - $148.76 $58,391 - $89,256
600 Added 23.85%
3,116 $340,000
Q3 2018

Oct 16, 2018

BUY
$115.31 - $161.51 $290,119 - $406,359
2,516 New
2,516 $406,000
Q2 2018

Jul 19, 2018

SELL
$71.74 - $153.69 $19,728 - $42,264
-275 Closed
0 $0
Q1 2018

Apr 10, 2018

SELL
$54.02 - $82.27 $12,154 - $18,510
-225 Reduced 45.0%
275 $20,000
Q3 2017

Oct 13, 2017

BUY
$35.73 - $47.15 $17,865 - $23,575
500
500 $23,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.5B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.